Get started
Author

Sven Golfier

Observed names: S Golfier, S. Golfier, SVEN GOLFIER
ORCID: 0009-0005-6506-8182
Observed ORCID: 0009-0005-6506-8182
OpenAlex ID: A5005024069
3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions
2014 · Carsten Wenzel, Björn Riefke, et al. · Experimental Cell Research · 266
PDF
Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect
2014 · Sven Golfier, Charlotte Kopitz, et al. · Molecular Cancer Therapeutics · 254
The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models
2019 · Antje M. Wengner, Gerhard Siemeister, et al. · Molecular Cancer Therapeutics · 213
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions
2008 · Martin A. Sieber, Philipp Lengsfeld, et al. · European Radiology · 204
PDF
Sphingosine‐1‐phospate receptor 4 (S1P 4 ) deficiency profoundly affects dendritic cell function and T H 17‐cell differentiation in a murine model
2011 · Tobias Schulze, Sven Golfier, et al. · The FASEB Journal · 118
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers
2019 · Urs B. Hagemann, Christine Ellingsen, et al. · Clinical Cancer Research · 117
Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4
2010 · Sven Golfier, Shinichi Kondo, et al. · The FASEB Journal · 90
Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair
2000 · A Klein, O Miera, et al. · Leukemia · 62
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
2016 · Sonja Textor, Felicitas Bossler, et al. · OncoImmunology · 58
PDF
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models
2018 · Maria Quanz, Urs B. Hagemann, et al. · Oncotarget · 57
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
2016 · Xiao-Yan Zhao, Babu Subramanyam, et al. · Clinical Cancer Drugs · 49
Dicentric chromosomes and -H2AX foci formation in lymphocytes of human blood samples exposed to a CT scanner: a direct comparison of dose response relationships
2009 · S. Golfier, G. Jost, et al. · Radiation Protection Dosimetry · 46
Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
2017 · Jörg Willuda, Lars Linden, et al. · Molecular Cancer Therapeutics · 45
The influence of x-ray contrast agents in computed tomography on the induction of dicentrics and γ-H2AX foci in lymphocytes of human blood samples
2009 · G Jost, S Golfier, et al. · Physics in Medicine and Biology · 45
T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
2021 · Jessica Pinkert, Hans-Henning Boehm, et al. · OncoImmunology · 44
PDF
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
2025 · Franziska Siegel, Stephan Siegel, et al. · Cancer Discovery · 28
Evaluating the role of zinc in the occurrence of fibrosis of the skin: A preclinical study
2009 · Hubertus Pietsch, Christiane Pering, et al. · Journal of Magnetic Resonance Imaging · 24
PDF
Role of Homeostatic Chemokine and Sphingosine‐1‐Phosphate Receptors in the Organization of Lymphoid Tissue
2003 · GERD MÜLLER, PHILLIP REITERER, et al. · Annals of the New York Academy of Sciences · 22
BAY 2927088: The first non-covalent, potent, and selective tyrosine kinase inhibitor targeting EGFR exon 20 insertions and C797S resistance mutations in NSCLC
2022 · F. Siegel, S. Siegel, et al. · European Journal of Cancer · 17
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
2024 · Keith Graham, Philip Lienau, et al. · Cell chemical biology · 16
Photoelectric‐enhanced radiation therapy with quasi‐monochromatic computed tomography
2009 · Gregor Jost, Tristan Mensing, et al. · Medical Physics · 16
Imaging-therapy computed tomography with quasi-monochromatic X-rays
2008 · Gregor Jost, Sven Golfier, et al. · European Journal of Radiology · 12
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
2020 · Julia Huetter, Uwe Gritzan, et al. · Cancer Immunology Research · 11
Abstract 836: ATR inhibitor BAY 1895344 shows potent anti-tumor efficacy in monotherapy and strong combination potential with the targeted alpha therapy Radium-223 dichloride in preclinical tumor models
2017 · Antje Margret Wengner, Gerhard Siemeister, et al. · Cancer Research · 11
Abstract 1754: Identification of BAY 94-9343, a mesothelin antibody-drug conjugate (ADC): Characterization and anti-tumor activity in mesothelin-positive preclinical tumor models
2011 · Sven Golfier, Antje Kahnert, et al. · Cancer Research · 5
Works count: 105
Citation count: 1,844
H-index: 18
I10-index: 24
Year
Topic
Type